Paladin, I agree. But just how positive and "material" can it be without a NR? So, while I think it will be positive, doesn't seem it will be very substantive. I mean, can you announce a partnership, and/or new FDA study structure/timing without a NR? During an "open" market? ... seems like "all is good, future is bright, we are progressing our study and partnering interest, money is not a concern, we continue to believe we have a clear path to commerialization nothing has changed, here is a review of the public data" again ... "will get back to you soon"?

... unless a NR pounts out at 10:59 ...